Uss Investment Management LTD Catalent, Inc. Transaction History

Uss Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $557,759 - $633,473	12,619 Added 19.22%	78,278 $3.56 Million
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $1.14 Million - $1.86 Million	25,057 Added 61.71%	65,659 $4.31 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $111,753 - $218,700	2,700 Added 7.12%	40,602 $1.83 Million
Q3 2022 Nov 08, 2022	SELL	$72.36 - $113.1 $607,389 - $949,361	-8,394 Reduced 18.13%	37,902 $2.75 Million
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $220,703 - $288,660	-2,531 Reduced 5.18%	46,296 $4.97 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $1.06 Million - $1.4 Million	11,233 Added 29.88%	48,827 $5.42 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $4.1 Million - $5.35 Million	37,594 New	37,594 $5 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Uss Investment Management LTD with notifications on news.